Products Categories
CAS No.: | 80621-81-4 |
---|---|
Name: | Rifaximin |
Article Data: | 1 |
Molecular Structure: | |
Formula: | C43H51N3O11 |
Molecular Weight: | 785.891 |
Synonyms: | L 105;L 105(ansamacrolide antibiotic);L 105SV;Rifamycin L 105;Rifamycin L 105SV;Xifaxan;refaximin; |
EINECS: | 617-130-4 |
Density: | 1.366 g/cm3 |
Melting Point: | 200-205 °C(dec) |
Appearance: | Red-orange crystalline powder |
PSA: | 198.38000 |
LogP: | 6.29580 |
rifaximin
Conditions | Yield |
---|---|
With ascorbic acid |
2-Amino-4-methylpyridine
rifaximin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: CHCl3 / 2 h / Ambient temperature 2: ascorbic acid View Scheme |
3-bromorifamicin S
rifaximin
Conditions | Yield |
---|---|
Multi-step reaction with 2 steps 1: CHCl3 / 2 h / Ambient temperature 2: ascorbic acid View Scheme |
Structure of Rifaximin (CAS NO.80621-81-4):
Empirical Formula: C43H51N3O11
Molecular Weight: 785.8785
Index of Refraction: 1.634
Molar Refractivity: 205.697 cm3
Molar Volume: 575.317 cm3
Polarizability: 81.545×10-24cm3
Surface Tension: 48.156 dyne/cm
Density: 1.366 g/cm3
Melting Point: 200-205°C(dec)
Physical Appearance: Red-Orange Crystalline Powder
Product Categories: Active Pharmaceutical Ingredients;Antibacterial;Intermediates & Fine Chemicals;Pharmaceuticals
Synonyms of Rifaximin (CAS NO.80621-81-4): (2S,16Z,18E,20S,21S,22R,23R,24R,25S,26S,27S,28E)-5,6,21,23,25 Pentahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)benzofuro(4,5-e)pyrido(1,2-a)benzimidazole-1,15(2H)-dione, 25-acetate ; 4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4-c)rifamycin SV ; Fatroximin ; Normix ; Rifacol .
Rifaximin (CAS NO.80621-81-4) is highly effective at preventing and treating traveler's diarrhea among travelers to Mexico, with few side effects and low risk of developing antibiotic resistance. In the United States, Rifaximin has orphan drug status for the treatment of hepatic encephalopathy.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | > 2gm/kg (2000mg/kg) | Drugs of the Future. Vol. 7, Pg. 260, 1982. | |
rat | LD50 | oral | > 2gm/kg (2000mg/kg) | Chemioterapia. Vol. 5, Pg. 263, 1986. |
RTECS: KD1576000